Analysis of docetaxel therapy in elderly (⩾70years) castration resistant prostate cancer patients enrolled in the Netherlands Prostate Study
Frank L. Gerritse(Tergooi), Maartje Los(St. Antonius Ziekenhuis), Tineke J. Smilde(Champalimaud Foundation), R.J.B. Blaisse(Rijnstate Hospital), Ankie M.T. van der Velden, Hielke J. Meulenbeld(Erasmus MC), Jeanine M.L. Roodhart(University Medical Center Utrecht), Ronald de Wit(Erasmus MC Cancer Institute), Z. Erjavec(National Institutes of Health)
Cited by 33
Related Papers
Preoperative Chemoradiotherapy for Esophageal or Junctional Cancer
|New England Journal of Medicine|2012|5.5k
Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma
|New England Journal of Medicine|2017|3.4k
Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial
|The Lancet Oncology|2015|2.6k
Defining Opportunistic Invasive Fungal Infections in Immunocompromised Patients with Cancer and Hematopoietic Stem Cell Transplants: An International Consensus
|Clinical Infectious Diseases|2002|2.3k
70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer
|New England Journal of Medicine|2016|2k